Drug Shortage Report for PRIMAQUINE
Report ID | 199221 |
Drug Identification Number | 02017776 |
Brand name | PRIMAQUINE |
Common or Proper name | PRIMAQUINE |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PRIMAQUINE PHOSPHATE |
Strength(s) | 26.3MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | P01BA |
ATC description | ANTIMALARIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-07-17 |
Estimated end date | 2023-07-28 |
Actual end date | 2023-07-20 |
Shortage status | Resolved |
Updated date | 2023-07-21 |
Company comments | Logistics system issue |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-07-21 | English | Compare |
v4 | 2023-07-20 | French | Compare |
v3 | 2023-07-20 | English | Compare |
v2 | 2023-07-19 | French | Compare |
v1 | 2023-07-19 | English | Compare |
Showing 1 to 5 of 5